SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 2nd, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Second Amended and Restated Employment Agreement (“Agreement”) is made this 2nd day of October 2017 (the “Effective Date”) between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”) and a wholly-owned subsidiary of CRISPR Therapeutics AG (“Parent”), and Samarth Kulkarni (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
